Carolina Biooncology Institute - NC Mecklenburg, Huntersville 28078

Carolina Biooncology Institute entered the industry of Doctors in 2005 and has grown to employ 1 to 4 people, generating an annual revenue of $2.500.000 to $4.999.999. The NAICS classifies this business under the code 6211110, which describes it as a Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Doctors. The business provides service to the B2C market.

To acquire more information, please contact John Powderly, Owner by calling (704) 947-6599 during business hours. You can also write to the business’ Single Location at 9801 Kincey Avenue # 145, Huntersville, North Carolina NC 28078. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Carolina Biooncology Institute
Representative: John Powderly, Owner
Place of Business: 9801 Kincey Avenue # 145, Huntersville, NC 28078
Contact Number: (704) 947-6599
Type of Service: Doctors
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2005
Income/Year: $2.500.000 to $4.999.999
Laborers: 1 to 4
Share This Company:

Carolina Biooncology Institute is a company operating from Mecklenburg, North Carolina providing professional Doctors and relevant B2C variables. It was founded in 2005 and registered with the SIC code 8011 as Doctors, and with the NAICS code 6211110 as Doctors.

With a current employee count of 1 to 4, Carolina Biooncology Institute has gone to report making $2.500.000 to $4.999.999 per annum on its journey towards growth. This company invites you to contact its representative John Powderly, Owner at (704) 947-6599 for related queries, or to locate its Single Location using the coordinates 35.404121,-80.864153.

The Single Location can also be found at the street address 9801 Kincey Avenue # 145 in Huntersville, North Carolina 28078 and can be engaged online through the company website at , the company Twitter , and Facebook page .